补肾护骨胶囊治疗骨质疏松症的临床经验及机制探讨
Clinical Experience and Mechanism of Bushen Hugu Capsule in Treating Osteoporosis
DOI: 10.12677/acm.2025.1572111, PDF,   
作者: 杨卓陶:重庆医科大学中医药学院,重庆;王淑美*:重庆医科大学中医药学院,重庆;重庆中医药学院中西医结合学院,重庆;万成绪:重庆市垫江县中医院中医骨伤科,重庆
关键词: 骨质疏松症补肾护骨胶囊肾主骨中医药疗法医案Osteoporosis Bushen Hugu Capsule The Kidneys Govern the Bones Traditional Chinese Medicine Therapy Medical Case
摘要: 目的:探讨补肾护骨胶囊治疗骨质疏松症(OP)的临床疗效及潜在作用机制。方法:通过分析典型医案,结合中医理论及现代药理学研究,系统阐述补肾护骨胶囊的组方原理及临床应用。结果:65岁女性OP患者经补肾护骨胶囊治疗4周后,腰背疼痛VAS评分降低40%,骨代谢指标(β-CTX, P1NP)显著改善(P < 0.05)。方中淫羊藿、紫河车等药物可能通过调控RAGE/NF-κB信号通路抑制骨吸收。结论:补肾护骨胶囊通过多靶点、多通路发挥抗骨质疏松作用,体现中医“肾主骨”理论的科学内涵。
Abstract: Objective: To explore the clinical efficacy and potential mechanism of action of Bushen Hugu Capsule in the treatment of osteoporosis (OP). Method: By analyzing typical medical cases, combined with traditional Chinese medicine theory and modern pharmacological research, the formula principle and clinical application of Bushen Hugu Capsule were systematically expounded. Result: After a 65-year-old female OP patient was treated with Bushen Hugu Capsule for 4 weeks, the VAS score of low back pain decreased by 40%, and the bone metabolism indicators (β-CTX, P1NP) were significantly improved (P < 0.05). Drugs such as Epimedium and Zihexia in the formula may inhibit bone resorption by regulating the RAGE/NF-κB signaling pathway. Conclusion: Bushen Hugu Capsules exert anti-osteoporosis effects through multiple targets and pathways, embodying the scientific connotation of the theory in traditional Chinese medicine that “the kidney governs the bones”.
文章引用:杨卓陶, 王淑美, 万成绪. 补肾护骨胶囊治疗骨质疏松症的临床经验及机制探讨[J]. 临床医学进展, 2025, 15(7): 1192-1198. https://doi.org/10.12677/acm.2025.1572111

参考文献

[1] 中华医学会骨质疏松分会. 原发性骨质疏松症诊疗指南(2022) [J]. 中华骨科杂志, 2022, 42(10): 591-610.
[2] 李灿东, 等. “肾主骨”理论的现代生物学基础研究进展[J]. 中国中药杂志, 2021, 46(3): 512-520.
[3] Chinese Society of Osteoporosis and Bone Mineral Research (2022) Guidelines for the Diagnosis and Management of Primary Osteoporosis (2022 Version). Chinese Journal of Osteoporosis and Bone Mineral Research, 15, 573-611.
[4] 周俏苑, 陈洪, 刘海全, 等. 基于网络药理学和分子对接探讨护骨胶囊治疗骨质疏松症的作用机制[J]. 现代药物与临床, 2023, 38(10): 2427-2435.
[5] 中华医学会骨质疏松和骨矿盐疾病分会, 章振林. 原发性骨质疏松症诊疗指南(2022) [J]. 中国全科医学, 2023, 26(14): 1671-1691.
[6] 尚奇, 任辉, 沈耿杨, 等. 基于肾主骨生髓理论探讨老年性骨质疏松症的中医治疗[J]. 中医杂志, 2017, 58(16): 1433-1435.
[7] 王少君, 李艳, 刘红, 等. 中医理论对骨质疏松症发病机制的认识[J]. 世界中医药, 2013, 8(9): 1044-1048.
[8] 夏维波, 章振林, 林华, 等. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 1-19.
[9] 赵文静, 王历, 王芝兰, 等. 淫羊藿的药理作用及临床应用研究进展[J]. 中医药信息, 2016, 33(2): 105-108.
[10] 李炳如, 佘运初. 补肾药对下丘脑-垂体-性腺轴功能影响[J]. 中医杂志, 1984(7): 63-65.